Home of the World's Most Influential Journalists

 

                  

 

 

 




Blogging NewsBios


Enter Your Email Below

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our E-Briefing

ORDER HERE

New Pricing Effective 2010

 Search for a Profile:

A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
 

 

Home

Pricing/Ordering 

FREE NEWSLETTER

Existing Profiles 

Why our Profiles?

FREE NEWSBIOS ON DEMAND

30 Under 30

Client Testimonials

Journalist Comments

Media Outlets

Exclusive Journalists' Interviews

Blogging NewsBios

The World's Most Influential
Health & Medical Journalists

BLOG TOPICS:

John Acher - Reuters 

Cristina Alesci - Bloomberg

Rob Cox - Breakingviews


Automotive Writers  

Julia Boorstin - CNBC

Jessica Hall - Reuters

Bob Herbert - NYT

Rob Schmitz - KQED


Wash Post Journalists Discover a Resilient USA

Time's Alice Park - Health Journalist of the Month

Coverage of Peanut Butter Recall: Gardiner Harris

FT's Andrew Jack Has the Scoop on Sanofi-Aventis

Health Journalism Today

Recently Updated health.newsbios*:

Associated Press:

• Linda A. Johnson
• Lauran Neergaard
• Matthew Perrone

Bloomberg News:

• Kristen Hallam
• John Lauerman
• Elizabeth Lopatto
• Shannon Pettypiece
• Tom Randall
• Lisa Rapaport
• Albertina Torsoli
• Angela Zimm

BusinessWeek:

• Catherine Arnst
• Arlene Weintraub

Dow Jones Newswire:

• Jennifer Corbett-Dooren
• Jared A. Favole
• Peter Loftus

Financial Times:

• Andrew Jack

Forbes:

• Matthew Herper
• Robert Langreth

New York Times:

• Reed Abelson
• Gardiner Harris
• Robert Pear
• Natasha Singer
• Duff Wilson


Reuters:

• Bill Berkrot
• Susan Heavey
• Lewis Krauskopf
• Ransdell Pierson
• Lisa Richwine

Wall Street Journal:

• John Carreyrou
• Vanessa Fuhrmans
• Jacob Goldstein
• Avery Johnson
• Anna Wilde Mathews
• Alicia Mundy
• Jonathan D. Rockoff
• Shirley S. Wang
• Jeanne Whalen
• Ron Winslow
• Jane Zhang

Other:

• Susan Dentzer, Health Affairs, Editor-in-Chief
• Katherine Eban, Freelance Investigative Health Care Reporter/ABC News
• Mike Huckman, Pharmaceutical Reporter, CNBC
• Alice Park, Senior Writer, TIME
• Bernadette Tansey, Staff Writer, San Francisco Chronicle

* Dozens of additional health.newsbios also available. Call for details.

Media Strategies Workshops and Dean Rotbart's Newsroom Confidential Column or CLASSROOM Edition.

 

 Tote Bag

Buy Cool Stuff!



 

 

Deanâs List

Kurt Succeeded When So Many Others Might Have Quit

By Dean Rotbart

 

Itâs been 15 years since Kurt mustered the courage to reveal his frightening secret in the well-thumbed pages of The New York Times Sunday Magazine. Back then, he was a cherubic 25-year-old reporter who some seasoned Times editor had shoved in the general direction of the financial pages. Kurt went.

When his 4,000-word magazine article appeared, in January 1987, even the Times didnât know how to describe young Kurtâs editorial responsibilities, so the short bio appended to the article noted only that Kurt ăis on the staff.ä

In ăBraving Epilepsyâs Storm,ä Kurt offered a first-hand account of the medical and emotional upheaval that followed his diagnosis, at age 18, with the seizure disorder.

ăAs the electrical firestorm sweeps across my brain, I lose consciousness and fall to the ground,ä Kurt wrote in describing a typical seizure, of which he had had hundreds. ăThe muscles in my body tighten up and my jaw clenches, the teeth possibly biting and bloodying my lips, tongue or cheek. My body jerks for a period, usually for less than a minute. During that time, I often get excessive amounts of saliva in my mouth, creating a froth. My breathing becomes irregular, sometimes even stopping. I also can become incontinent.ä

Challenging as it was for the 18-year-old Kurt to face the physical manifestations of his illness, it was perhaps even more daunting to come to terms with the social stigma and misunderstanding attached to his condition.

His doctor and members of his family cautioned Kurt to keep his epilepsy a secret, lest he become a social and workplace pariah. Even Kurtâs father, a noted pediatrician, went through a long period of denial.

Early in his junior year at Swarthmore College in Pennsylvania, Kurt was making progress in managing and reducing the frequency of his seizures. After a series of revolving door doctors, Kurt found one who really knew his stuff and the doctor put Kurt on a far more effective medication.

Kurt allowed himself a little extra leeway, which resulted in experiencing two seizures outdoors on campus. In the aftermath of those events, the Swarthmore College administration dismissed Kurt from school, citing his health problems.

Kurt was filled with a rage so intense that he and his family worried for his sanity. Kurt never expected to see his college graduation. He didnât think heâd live that long.

----------------

Kurt was back in the New York Times this past Sunday; this time on the front page. His subject matter was not epilepsy, but Enron. In a lengthy article, Kurt traces the roots and ramifications of the giant energy and finance companyâs spectacular collapse. If not for the terrorist attacks on September 11th and their aftermath, no doubt Enron would have been the biggest business story of 2001.

Today Kurt is one of the best business investigative reporters in the country.

As with the Enron story, he has the ability to probe complex stories and make them understandable and compelling. Heâs explored the funding for Osama bin Ladenâs terrorist network; heâs examined the last minute pardons President Bill Clinton made of businessmen and others; he wrote at length about mismanagement at the Columbia/HCA Healthcare Corp. and about blunders at Prudential Bache & Co.

It was Kurt who broke the story about discriminatory employment practices at Texaco Corp. and who detailed the racially charged conversations at the highest executive levels of the petroleum giant.

Kurtâs extensive reporting on the price-fixing case against Archer Daniels Midland (ADM) was the foundation for his most recent book, The Informant: A True Story, which has been both a critical and popular success.

For his various reporting efforts, Kurt has won more than his fair share of recognition. My company, TJFR Group, has repeatedly honored him as one of the 100 most influential business journalists in the country and as a ăBlue Chipä investigative reporter.

Kurt was a Pulitzer Prize finalist in 2000, a finalist for the prestigious Goldsmith Prize in 1998 and a two-time winner of the George Polk award.

This past August, Kurt and his family relocated from the New York area to Dallas, where he grew up and where his parents still reside. So valuable is he to the Times, the paper doesnât really care much where Kurt lives or works, just so that his byline resides in The New York Times.

Kurtâs climb from the depths of despair after being expelled from college to the pinnacle of the business journalism profession is a story of unbelievable perserverence and determination. A lesser person would have quit many times and rightfully blamed his illness for his failures.

But while Kurt despaired a great deal, he never quit. With the help of his family, college roommates and, eventually, a savvy doctor, Kurt found the correct medication to control his seizures and eventually put an end to them all together. Itâs been nine years now that Kurt is seizure free.

With help he received from the governmentâs Health and Human Services, lawyers and his family, Kurt persuaded Swarthmore College to readmit him in the second semester of his junior year. He graduated with distinction in June 1983 and has gone on to be a great source of pride to his alma mater.

For all his professional success and recognition, Kurt continues to be both warm and humble. In a recent phone conversation, he told me of his investigative method: ăI think the only talent I have is the ability to recognize that there are a lot of things that I donât know.

ăIâm willing to say that ÎI donât know.äâ Kurt says. ăThe process of learning is always the same. You go to the people who know what they are talking about. You throw your ignorance out there as completely as you can and try to figure out what youâre dealing with.ä

Kurt adds that ăhe was been very lucky over the years because most of the time Iâve been able to figure things out.ä

Reflecting on his New York Times Magazine article 15 years ago, Kurt says that he felt he had no choice but to write about his epilepsy. ăI had the opportunity and platform to talk about something that affects a lot of people and to talk about it in a way that I wish someone had talked about it when I was going through it. To know that and do nothing about it really wasnât an option.ä

While Kurt has never since hidden his epilepsy, he also didnât make it a centerpiece of his life. After writing his story, Kurtâs mission was clear and it was not to become a poster boy for the illness.

ăMy whole life from the time I got sick was focused on making sure that I was a student, a journalist, a husband and a father,ä Kurt tells me. ăNot that I was someone with this condition.ä

Well he succeeded quite spectacularly. And that is why Kurt Eichenwald, investigative business reporter for The New York Times, is the first entry on my ăDeanâs Listä of the most unforgettable journalists I know.

January 14, 2002

 

Back to Article Archives    Newsroom Confidential Home 

Guest Archives

 








The Journalist's Store




Site Sponsors Include:

Best Journalism Schools
Editor-in-Chief.com
Hopeless Utopian

NewsBios-on-Demand


 


 

POWERED BY: You, Here, Now!

Home Page      Newsroom Confidential Home    Order Form    About Us    About TJFR   

Guest Column Archives   Newsroom Confidential Archives

 

Hit Counter

        A Division of the TJFR Group, Inc.

        2020 Arapahoe Street/Lower Level

        Denver, CO 80205

        P:  1.866.NEWS.070 ext. 2  F:  720.528.7821

        E:  TJFR@NewsBios.com

Last modified: February 12, 2010                  

Copyright © 2010  NewsBios                                                                                                                            

 

All copyright, content and publishing are solely proprietary rights of the TJFR Group and NewsBios and remain proprietary to TJFR Group and NewsBios.  TJFR reserves its entire right, title and interest in and to the Database ( NewsBios) and all Intellectual Property Rights therein.